CD28

CD28

CD28 Overview

Molecule Name
T-cell-specific surface glycoprotein CD28
Synonyms
CD28,Tp44
Drug Development Progress
Drugs in Clinical Trials32
Approved Drugs0
Highest Development StagePhase 2 Clinical
Target Synonym
CD28,CD28 Antigen,T-Cell-Specific Surface Glycoprotein CD28,CD28 Antigen (Tp44),Tp44,CD28 Antigens,CD28 Molecule,T-Cell-Specific Surface Glycoprotein
Background
T-cell-specific surface glycoprotein CD28 is also known as TP44, is a single-pass type I membrane protein which contains one Ig-like V-type (immunoglobulin-like) domain. is one of the molecules expressed on T cells that provide co-stimulatory signals, which are required for T cell activation. CD28 is the receptor for CD80 (B7.1) and CD86 (B7.2). When activated by Toll-like receptor ligands, the CD80 expression is upregulated in antigen presenting cells (APCs). The CD86 expression on antigen presenting cells is constitutive. CD28 is the only B7 receptor constitutively expressed on naive T cells.

CD28 Product List

Species
  • Human / Cynomolgus / Rhesus macaque(5)
  • Mouse(3)
  • Rat(1)
Tag
  • His Tag(3)
  • Fc Tag(2)
  • His Tag & Avi Tag(2)
  • Fc Tag & Avi Tag(1)
  • Mouse IgG Fc Tag(1)
Host
  • HEK293(9)
Conjugate
  • Unconjugated(6)
  • Biotin-labeled(3)
Grade
  • RUO(9)
Low Endotoxin
  • Yes(2)
  • No(7)
MoleculeCat. No.Product NameSpeciesHostStructurePurityActivitySize&Price
CD28
Biotinylated Human / Cynomolgus / Rhesus macaque CD28 Protein, Fc,Avitag™, active dimer (HPLC verified)
Human / Cynomolgus / Rhesus macaque
HEK293
HPLCSDS-PAGE
ELISABLI

$270.00

25ug
CD28
HOTAvitag
CD8-H82E5
Biotinylated Human / Cynomolgus / Rhesus macaque CD28 Protein, His,Avitag™, active dimer (MALS verified)
Human / Cynomolgus / Rhesus macaque
HEK293
MALSSDS-PAGE
ELISA

$260.00

25ug
CD28
Human / Cynomolgus / Rhesus macaque CD28 Protein, His Tag, active dimer, low endotoxin (Mass Spec & MALS verified)
Human / Cynomolgus / Rhesus macaque
HEK293
MALSSDS-PAGE
ELISABLI

$380.00

100ug
CD28
Human / Cynomolgus / Rhesus macaque CD28 Protein, Fc Tag, active dimer, low endotoxin (MALS verified)
Human / Cynomolgus / Rhesus macaque
HEK293
MALSSDS-PAGE
ELISASPRBLI

$205.00

100ug
CD28
Human / Cynomolgus / Rhesus macaque CD28 Protein, Mouse IgG2a Fc Tag (MALS verified)
Human / Cynomolgus / Rhesus macaque
HEK293
MALSSDS-PAGE
ELISABLI

$340.00

100ug
CD28
Mouse CD28 Protein, Fc Tag (MALS & BLI verified)
Mouse
HEK293
MALSSDS-PAGE
BLI

$225.00

100ug
CD28
Mouse CD28 Protein, His Tag, active dimer (MALS verified)
Mouse
HEK293
MALSSDS-PAGE
ELISA

$345.00

100ug
CD28
Avitag
CD8-M82E3
Biotinylated Mouse CD28 Protein, His,Avitag™, active dimer (MALS verified)
Mouse
HEK293
MALSSDS-PAGE
ELISA

$260.00

25ug
CD28
Rat CD28 Protein, His Tag (BLI verified)
Rat
HEK293
SDS-PAGE
BLI

$330.00

100ug
You Have Viewed 1-9 Of 9 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity
Resources

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
NezastomigREGN-5678Phase 2 ClinicalRegeneron Pharmaceuticals Inc
Carcinoma, Renal Cell; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant
Details
Abatacept (Orban Biotech)Phase 2 ClinicalOrban Biotech, The National Institute Of Diabetes And Digestive And Kidney Diseases
Diabetes Mellitus, Type 1
Details
Lulizumab pegolLulizumab; BMS-931699Phase 2 ClinicalBristol-Myers Squibb Company
Lupus Vulgaris; Rejection of renal transplantation; Sjogren-Larsson Syndrome
Details
AcazicolceptALPN-101Phase 2 ClinicalAlpine Immune Sciences Inc
Autoimmune Diseases; Graft vs Host Disease; Inflammation; Lupus Erythematosus, Systemic; Lymphoproliferative Disorders
Details
MDX-2003MDX-2003Phase 2 ClinicalModeX Therapeutics Inc
Autoimmune Diseases; Leukemia, B-Cell; Lymphoma; Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Primary mediastinal B cell lymphoma; Waldenstrom Macroglobulinemia
Details
PegrizeprumentFR-104; JNJ-3133; VEL-101Phase 2 ClinicalEffimune
Arthritis, Rheumatoid; Postoperative Complications; Rejection of renal transplantation
Details
TC-510TC-510Phase 2 ClinicalTcr2 Therapeutics Inc
Carcinoma, Non-Small-Cell Lung; Cholangiocarcinoma; Colorectal Neoplasms; Mesothelioma; Ovarian Neoplasms; Pancreatic Neoplasms; Solid tumours; Triple Negative Breast Neoplasms
Details
REGN-17372REGN17372; REGN-17372Phase 2 ClinicalRegeneron Pharmaceuticals Inc
Multiple Myeloma
Details
ZGGS-34ZGGS34; ZGGS-34Phase 2 ClinicalSuzhou Zelgen Biopharmaceuticals Co Ltd
Solid tumours
Details
REGN-7945REGN7945; REGN-7945Phase 2 ClinicalRegeneron Pharmaceuticals Inc
Multiple Myeloma
Details
MDX-2001MDX2001; MDX-2001Phase 2 ClinicalModeX Therapeutics Inc
Biliary Tract Neoplasms; Breast Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Colonic Neoplasms; Endometrial Neoplasms; Esophageal Neoplasms; Head and Neck Neoplasms; Kidney Neoplasms; Pancreatic Neoplasms; Prostatic Neoplasms; Rectal Neoplasms; Stomach Neoplasms; Thyroid Neoplasms; Uterine Cervical Neoplasms
Details
MarlotamigREGN-7075Phase 2 ClinicalRegeneron Pharmaceuticals Inc
Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Solid tumours
Details
REGN-5668REGN-5668Phase 2 ClinicalRegeneron Pharmaceuticals Inc
Endometrial Neoplasms; Fallopian Tube Neoplasms; Ovarian Neoplasms; Peritoneal Neoplasms
Details
ATLCAR.k.CD28 cells (UNC Lineberger Comprehensive Cancer Center)Phase 1 ClinicalUnc Lineberger Comprehensive Cancer Center
Lymphoma; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Follicular; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin
Details
SAR-442257SAR-442257Phase 1 ClinicalSanofi
Neoplasms
Details
Autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T cells (City of Hope Medical Center)Phase 1 ClinicalCity Of Hope National Medical Center
Lymphoma, Non-Hodgkin
Details
B7-H3.CD28Z.CART therapy (Band Of Parents)Phase 1 ClinicalThe Band Of Parents
Neuroblastoma; Solid tumours
Details
HLX-3901HLX-3901Phase 1 ClinicalShanghai Henlius Biotech Inc
Carcinoma, Neuroendocrine; Neoplasm Metastasis; Small Cell Lung Carcinoma; Solid tumours
Details
SSS-59SSS59; SSS-59Phase 1 ClinicalShenyang Sunshine Pharmaceutical Co Ltd
Neoplasms
Details
RNDO-564RNDO-564Phase 1 ClinicalRondo Therapeutics
Carcinoma; Carcinoma, Non-Small-Cell Lung; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Neoplasms; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Triple Negative Breast Neoplasms; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms
Details
SAR-446422SAR446422; SAR-446422Phase 1 ClinicalSanofi
Autoimmune Diseases
Details
JNJ-1493JNJ-1493Phase 1 ClinicalXencor Inc
Hematologic Neoplasms; Lymphoma, B-Cell
Details
JNJ-9401JNJ-9401Phase 1 ClinicalXencor Inc
Prostatic Neoplasms
Details
SM-2275SM-2275; SM2275Phase 1 ClinicalZhuhai StarMab BioMed Technology Ltd
Solid tumours
Details
JNJ-87189401JNJ-87189401Phase 1 ClinicalJanssen Research & Development Llc
Prostatic Neoplasms
Details
REGN5837REGN5837; REGN-5837Phase 1 ClinicalRegeneron Pharmaceuticals Inc
Lymphoma, Non-Hodgkin
Details
CC-312CC-312Phase 1 ClinicalCytoCares (Shanghai) Inc
Anemia, Hemolytic, Autoimmune; Arthritis, Rheumatoid; Hematologic Neoplasms; Leukemia, Lymphocytic, Chronic, B-Cell; Lupus Erythematosus, Systemic; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Myositis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Purpura, Thrombocytopenic, Idiopathic; Scleroderma, Systemic
Details
XmAb-808XmAb808Phase 1 ClinicalXencor Inc
Carcinoma, Non-Small-Cell Lung; Carcinoma, Ovarian Epithelial; Carcinoma, Renal Cell; Carcinoma, Transitional Cell; Colorectal Neoplasms; Melanoma; Prostatic Neoplasms, Castration-Resistant; Squamous Cell Carcinoma of Head and Neck; Triple Negative Breast Neoplasms
Details
SAR-443216SAR-443216Phase 1 ClinicalSanofi
Breast Neoplasms; Lung Neoplasms; Neoplasms; Solid tumours; Stomach Neoplasms
Details
CD19 PD-1/CD28 CAR-T Cell Therapy (Second Affiliated Hospital School Of Zhejiang University School Of Medicine)Phase 1 ClinicalSecond Affiliated Hospital Of Zhejiang University School Of Medicine
Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Primary mediastinal B cell lymphoma
Details
B7-2/GM-CSF cancer gene therapyCITPhase 1 ClinicalRadient
Neoplasms
Details
InHeAb-01InHeAb-01; bsABClinicalUniversity Hospital Tuebingen
Neoplasms
Details
Customer Reviews